Wolverine Trading’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Wolverine Trading’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,340	Closed	-$52.3K	–	5319
2023 Q2	$52.3K	Buy	1,340 +240	+22%	+$8.46K	﹤0.01%	3942
2023 Q1	$29K	Buy	+1,100	New	+$37.3K	﹤0.01%	3953
2022 Q4	–	Sell	-356	Closed	-$44K	–	5433
2022 Q3	$44K	Sell	356 -23	-6%	-$4.14K	﹤0.01%	4186
2022 Q2	$65K	Buy	+379	New	+$79.9K	﹤0.01%	3992
2022 Q1	–	Sell	-557	Closed	-$297K	–	6862
2021 Q4	$297K	Buy	557 +421	+310%	+$302K	﹤0.01%	4175
2021 Q3	$37K	Buy	136 +39	+40%	+$16.7K	﹤0.01%	6068
2021 Q2	$86K	Buy	+97	New	+$74.2K	﹤0.01%	5473

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wolverine Trading's BIOR Position: Q4 2022 in Review

Wolverine Trading sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2022, closing a stake of 293 shares — an estimated $36K sold.

Wolverine Trading first reported a position in BIOR in Q3 2021 and held it in 4 quarters. The position peaked at $257K in Q4 2021. 42 funds tracked by Wall St. Rank hold BIOR as of Q4 2022.

Wolverine Trading reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Wolverine Trading sold 293 Biora Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $36K.
Wolverine Trading first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Wolverine Trading's Biora Therapeutics, Inc. Common Stock position peaked at $257K in Q4 2021.
42 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.